⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL206183 | 1.00 | — | — | |
| SCHEMBL15341654 | 0.81 | — | — | |
| SCHEMBL12241744 | 0.81 | — | — | |
| SCHEMBL9604976 | 0.81 | — | — | |
| SCHEMBL10200821 | 0.75 | — | — | |
| SCHEMBL2808933 | 0.73 | — | — | |
| SCHEMBL1770651 | 0.73 | — | — | |
| SCHEMBL22984154 | 0.69 | — | — | |
| SCHEMBL20055507 | 0.69 | — | — | |
| SCHEMBL12444210 | 0.65 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 265 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4219511-A1 | INTERMEDIATE, PREPARING METHOD THEREOF, AND METHOD OF PREPARING DRUG | Heron Neutron Medical Corp. (TW) | 2023-08-02 | — | — | EP | claimed |
| US-20230234973-A1 | INTERMEDIATE, PREPARING METHOD THEREOF, AND METHOD OF PREPARING DRUG | HERON NEUTRON MEDICAL CORP. (TW) | 2023-07-27 | — | — | US | claimed |
| US-20260098060-A1 | MACROCYCLIC CFTR MODULATORS | IDORSIA PHARMACEUTICALS LTD (CH) | 2026-04-09 | — | — | US | disclosed |
| EP-4695260-A1 | KRAS MODULATING COMPOUNDS | GILEAD SCIENCES, INC. (US) | 2026-02-18 | — | — | EP | disclosed |
| US-20250340574-A1 | MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR | VERTEX PHARMA (US) | 2025-11-06 | — | — | US | disclosed |
| US-20250296915-A1 | NOVEL AMINO ACID DERIVATIVES | PEPTIDREAM INC (JP) | 2025-09-25 | — | — | US | disclosed |
| EP-4587443-A1 | MACROCYCLIC CFTR MODULATORS | Idorsia Pharmaceuticals Ltd (CH) | 2025-07-23 | — | — | EP | disclosed |
| WO-2025085554-A1 | LYSINE ACETYLTRANSFERASE INHIBITORS | Kronos Bio, Inc. (US) | 2025-04-24 | — | — | WO | disclosed |
| EP-4504739-A1 | MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR | Vertex Pharmaceuticals Incorporated (US) | 2025-02-12 | — | — | EP | disclosed |
| US-20240417388-A1 | BENZIMIDAZOLONE DERIVED INHIBITORS OF BCL6 | CANCER RESEARCH TECH LTD (GB) | 2024-12-19 | — | — | US | disclosed |
| US-12162888-B2 | Carboxamides as ubiquitin-specific protease inhibitors | VALO HEALTH, INC. (US) | 2024-12-10 | — | — | US | disclosed |
| WO-2003004498-A1 | BETA-AMINO TETRAHYDROIMIDAZO (1, 2-A) PYRAZINES AND TETRAHYDROTRIOAZOLO (4, 3-A) PYRAZINES AS DIPEPTIDYL PEPTIDASE INHIBITORS FOR THE TREATMENT OR PREVENTION OF DIABETES | MERCK & CO., INC. (US) | 2003-01-16 | — | — | WO | disclosed |
| EP-0934286-B1 | 3-ALKOXYISOXAZOL-4-YL-SUBSTITUTED 2-AMINO CARBOXYLIC ACID COMPOUNDS | LUNDBECK & CO AS H (DK) | 2003-01-08 | — | — | EP | disclosed |
| US-20010027174-A1 | Neo-tryptophan | MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH MINNESOTA CORPORATION | 2001-10-04 | — | — | US | disclosed |
| EP-1067950-A4 | NEO-TRYPTOPHAN | MAYO FOUNDATION FOR MEDICAL (US) | 2001-09-05 | — | — | EP | disclosed |
| US-6214790-B1 | POLYPEPTIDES OF NEOTRYPTOPHAN AND SYNTHESIS | MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH | 2001-04-10 | — | — | US | disclosed |
| US-6200999-B1 | ALZHEIMER*S, HUNTINGTON*S, AND PARKINSON*S DISEASE; ANTIEPILEPTIC, ANALGESIC, ANXIOLYTIC, ANTIISCHEMIC AND ANTIDEPRESSANT AGENTS; NMDA AND AMPA RECEPTOR LIGANDS | H. LUNDBECK A/S (DK) | 2001-03-13 | — | — | US | disclosed |
| EP-1067950-A1 | NEO-TRYPTOPHAN | MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH (US) | 2001-01-17 | — | — | EP | disclosed |
| CN-1238766-A | 3-Alkoxyisoxazol-4-yl-substituted-2-aminocarboxylic acid compounds | LUNDBECK & CO AS H (DK) | 1999-12-15 | — | — | CN | disclosed |
| WO-1999052539-A1 | NEO-TRYPTOPHAN | MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH (US) | 1999-10-21 | — | — | WO | disclosed |